Subtopic Deep Dive
Salivary Gland Tumor Molecular Classification
Research Guide
What is Salivary Gland Tumor Molecular Classification?
Salivary gland tumor molecular classification identifies specific fusion genes, mutations, and genomic alterations that define distinct tumor entities beyond histological features.
Key fusions include MYB-NFIB in adenoid cystic carcinoma (Brill et al., 2011, 364 citations) and EWSR1-ATF1 in hyalinizing clear-cell carcinoma (Antonescu et al., 2011, 394 citations). EWSR1 rearrangements occur in myoepithelial tumors (Antonescu et al., 2010, 489 citations). Over 10 major papers document these molecular drivers since 2010.
Why It Matters
Molecular classification enables precision diagnosis of salivary tumors like adenoid cystic carcinoma, distinguishing entities with overlapping histology (Seethala and Stenman, 2017, 388 citations). It identifies therapeutic targets, such as MYB-driven pathways in ACC (Ho et al., 2013, 454 citations; Brill et al., 2011). Fusion detection via FISH or NGS guides targeted therapies and improves prognosis over morphology alone (Antonescu et al., 2011).
Key Research Challenges
Fusion Detection Variability
Standardizing methods like FISH, NGS, and RT-PCR for fusions such as EWSR1-ATF1 remains inconsistent across labs (Antonescu et al., 2011). Histological overlap complicates pre-molecular diagnosis (Antonescu et al., 2010). Over 60 cases analyzed highlight detection challenges in rare sites (Antonescu et al., 2010).
Rare Tumor Genomics
Genomic profiling of low-prevalence tumors like hyalinizing clear-cell carcinoma yields limited samples for validation (Antonescu et al., 2011, 394 citations). Mutational landscapes in ACC reveal few recurrent drivers beyond fusions (Ho et al., 2013). Extraglandular myoepithelial tumors pose unique sequencing hurdles (Antonescu et al., 2010).
Translational Therapy Gaps
MYB-NFIB fusions in ACC lack direct inhibitors despite high prevalence (Brill et al., 2011; Ho et al., 2013). Integrating molecular data into WHO classification requires clinical trials (Seethala and Stenman, 2017). Perineural invasion in ACC persists despite molecular insights (Coca-Pelaz et al., 2015).
Essential Papers
Cutaneous and Mucosal Lichen Planus: A Comprehensive Review of Clinical Subtypes, Risk Factors, Diagnosis, and Prognosis
Farzam Gorouhi, Parastoo Davari, Nasim Fazel · 2014 · The Scientific World JOURNAL · 507 citations
Lichen planus (LP) is a chronic inflammatory disorder that most often affects middle-aged adults. LP can involve the skin or mucous membranes including the oral, vulvovaginal, esophageal, laryngeal...
Adenoid cystic carcinoma of the head and neck – An update
Andrés Coca‐Pelaz, Juan P. Rodrigo, Patrick J. Bradley et al. · 2015 · Oral Oncology · 490 citations
<i>EWSR1‐POU5F1</i> fusion in soft tissue myoepithelial tumors. A molecular analysis of sixty‐six cases, including soft tissue, bone, and visceral lesions, showing common involvement of the <i>EWSR1</i> gene
Cristina R. Antonescu, Lei Zhang, Ning‐En Chang et al. · 2010 · Genes Chromosomes and Cancer · 489 citations
Abstract The diagnosis of myoepithelial (ME) tumors outside salivary glands remains challenging, especially in unusual clinical presentations, such as bone or visceral locations. A few reports have...
The mutational landscape of adenoid cystic carcinoma
Allen S. Ho, Kasthuri Kannan, David M. Roy et al. · 2013 · Nature Genetics · 454 citations
Sjögren’s syndrome: a systemic autoimmune disease
Simone Negrini, Giacomo Emmi, Mónica Greco et al. · 2021 · Clinical and Experimental Medicine · 401 citations
Abstract Sjögren’s syndrome is a chronic autoimmune disease characterized by ocular and oral dryness resulting from lacrimal and salivary gland dysfunction. Besides, a variety of systemic manifesta...
<i>EWSR1‐ATF1</i> fusion is a novel and consistent finding in hyalinizing clear‐cell carcinoma of salivary gland
Cristina R. Antonescu, Nora Katabi, Lei Zhang et al. · 2011 · Genes Chromosomes and Cancer · 394 citations
Abstract Hyalinizing clear‐cell carcinoma (HCCC) is a rare, low‐grade salivary gland tumor with distinctive clear‐cell morphology and pattern of hyalinization as well as focal mucinous differentiat...
Update from the 4th Edition of the World Health Organization Classification of Head and Neck Tumours: Tumors of the Salivary Gland
Raja R. Seethala, Göran Stenman · 2017 · Head and Neck Pathology · 388 citations
Reading Guide
Foundational Papers
Start with Brill et al. (2011) for MYB-NFIB in ACC and other neoplasms; Antonescu et al. (2011) for EWSR1-ATF1 in clear-cell carcinoma; Ho et al. (2013) maps ACC mutations—these establish core fusions and genomics.
Recent Advances
Seethala and Stenman (2017, 388 citations) updates WHO salivary tumor classification; Coca-Pelaz et al. (2015, 490 citations) reviews ACC biology integrating molecular data.
Core Methods
Fusion detection by FISH/RT-PCR (Brill et al., 2011); NGS for landscapes (Ho et al., 2013); EWSR1 break-apart assays for myoepithelial/HCCC tumors (Antonescu et al., 2010, 2011).
How PapersFlow Helps You Research Salivary Gland Tumor Molecular Classification
Discover & Search
Research Agent uses searchPapers and citationGraph to map MYB-NFIB fusion literature from Brill et al. (2011), revealing 364 downstream citations. exaSearch uncovers EWSR1 fusions in rare salivary tumors; findSimilarPapers links Ho et al. (2013) mutational landscape to 454 related ACC genomics studies.
Analyze & Verify
Analysis Agent applies readPaperContent to extract fusion data from Antonescu et al. (2011), then verifyResponse with CoVe checks claims against Seethala and Stenman (2017). runPythonAnalysis processes mutation frequencies from Ho et al. (2013) via pandas for statistical validation; GRADE grading scores evidence strength for EWSR1-ATF1 consistency.
Synthesize & Write
Synthesis Agent detects gaps in MYB-targeted therapies post-Brill et al. (2011), flagging contradictions in ACC mutation rates (Ho et al., 2013). Writing Agent uses latexEditText and latexSyncCitations to draft WHO-aligned reviews (Seethala and Stenman, 2017), with latexCompile for publication-ready manuscripts and exportMermaid for fusion pathway diagrams.
Use Cases
"Extract mutation frequencies from Ho et al. 2013 ACC paper and plot with statistics"
Research Agent → searchPapers('Ho 2013 ACC mutational landscape') → Analysis Agent → readPaperContent → runPythonAnalysis(pandas frequency table, matplotlib barplot) → researcher gets CSV of validated mutation stats and GRADE-scored plot.
"Draft LaTeX review of EWSR1 fusions in salivary tumors citing Antonescu papers"
Research Agent → citationGraph('Antonescu EWSR1') → Synthesis Agent → gap detection → Writing Agent → latexEditText(structured review) → latexSyncCitations(10 papers) → latexCompile(PDF) → researcher gets compiled manuscript with diagrams.
"Find open-source NGS code for MYB-NFIB fusion detection from salivary tumor papers"
Research Agent → searchPapers('MYB-NFIB fusion detection code') → Code Discovery → paperExtractUrls → paperFindGithubRepo → githubRepoInspect → researcher gets annotated GitHub repos with fusion analysis scripts linked to Brill et al. (2011).
Automated Workflows
Deep Research workflow scans 50+ ACC papers via searchPapers, chains citationGraph on Ho et al. (2013), and outputs structured report on mutation-fusion correlations. DeepScan applies 7-step CoVe verification to EWSR1 claims in Antonescu et al. (2011), with runPythonAnalysis checkpoints. Theorizer generates hypotheses on MYB-NFIB therapy resistance from Brill et al. (2011) and Coca-Pelaz et al. (2015).
Frequently Asked Questions
What defines salivary gland tumor molecular classification?
It uses fusion genes like MYB-NFIB, EWSR1-ATF1, and mutations to classify tumors beyond histology (Brill et al., 2011; Antonescu et al., 2011).
What are key methods for molecular classification?
FISH, NGS, and RT-PCR detect fusions such as EWSR1 rearrangements; immunohistochemistry confirms MYB expression (Ho et al., 2013; Brill et al., 2011).
What are the most cited papers?
Ho et al. (2013, 454 citations) on ACC mutations; Antonescu et al. (2010, 489 citations) on EWSR1-POU5F1; Brill et al. (2011, 364 citations) on MYB-NFIB.
What open problems exist?
Developing targeted therapies for MYB fusions and standardizing NGS for rare tumors; clinical integration lags behind WHO updates (Seethala and Stenman, 2017; Ho et al., 2013).
Research Salivary Gland Tumors Diagnosis and Treatment with AI
PapersFlow provides specialized AI tools for Medicine researchers. Here are the most relevant for this topic:
Systematic Review
AI-powered evidence synthesis with documented search strategies
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Find Disagreement
Discover conflicting findings and counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
See how researchers in Health & Medicine use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Salivary Gland Tumor Molecular Classification with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Medicine researchers